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Introduction
The use of noninvasive ventilation (NIV) in patients
with acute hypercapneic respiratory failure has shown to be
effective in the relief of dyspnea, the improvement of vital
signs and gas exchange, in preventing endotracheal intubation,
and improving overall survival.1-6 It has now become the
standard of care for such patients.3,5
NIV is underused in Pakistan since most pulmonary
physicians in practice are either not trained in its usage or have
concerns regarding the time commitment that these patients
impose on the care process. There is dearth of literature on
how well NIV is tolerated in patient populations unique to our
region. This fact is especially unfortunate since NIV is a cost-
effective intervention; particularly for countries like Pakistan
where health care delivery is largely determined by the
patients' ability to pay for service. It is estimated in a study
from United Kingdom that NIV given on wards reduces the
need for intubation by 44% and halves mortality in hospital in
patients with chronic obstructive pulmonary disease and mild
to moderate acidosis and by preventing intubation, NIV may
help to avoid approximately three to nine ICU admissions per
year and consequently result in a substantial cost saving for
patients.7
There are some patients who do not respond to NIV
and in these, invasive ventilation becomes essential. Studies
from the West report failure rates of 24% to 50%.2,8 Delays in
recognizing non-responders can increase hospital morbidity
and mortality.8 In an effort to optimize outcomes, it is
therefore essential to identify non-responders early.
This study was designed to primarily asses the safety
and efficacy of NIV in hypercapneic acute respiratory failure
in Pakistani patients and additionally to identify prognostic
variables for survival, death and endotracheal intubation.
Patients and Methods
This observational cohort study was conducted
between 2001 and 2005 at Aga Khan University Hospital, a
450-bedded tertiary care hospital in Karachi, Pakistan. All
adult patients (aged 16 years or above) presenting with
hypercapneic acute respiratory failure (ARF) and meeting
criteria for non-invasive ventilation use were enrolled. The
hospital Ethics Committee approved the research protocol. 
Hypercapneic ARF was defined as the presence of all
the following: 
Respiratory rate higher than 25 breaths/minute, arterial
pH less than 7.35, and partial pressure of arterial carbon
dioxide (PaCO2) in excess of 45 mmHg. 
NIV failure was defined as endotracheal intubation
and invasive ventilation after placement on NIV and/or death.
In patients with multiple admissions during the study
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Abstract
Objective: To assess results with NIV in acute hypercapneic respiratory failure and to identify outcome
predictors.
Methods: This was a retrospective observational study on consecutive patients presenting with acute type II
respiratory failure and meeting criteria for NIV use over a 5 year period. Patients presenting with haemodynamic
instability, inability to protect their airway, malignant arrhythmias and recent oesophageal surgery were excluded.
Univariate and Multivariate regression analysis was used to determine the impact on survival. A p value of < 0.05
was considered statistically significant. Software used was SPSS 14.
Results: Total numbers of patients included were 119; 52.9% were males. Mean age was 63.4 ± 11.9 years.
Overall Survival to discharge rate was 76.5%, intubation rate was 12.6% and mean length of stay was 11.4 ±
10.9 days. Statistically significant improvements were observed in the pH and PaCO2 at 24 hours and 48 hours
compared to baseline (7.28 v/s 7.37, p<0.001; 74.2 v/s 65, p<0.001). On multivariate regression analysis, sepsis
at admission predicted mortality (adjusted Odds ratio 26.4; 95% CI 2.3, 304, p < 0.009). A serum HCO3 > 35
Meq/L (adjusted Odds ratio 0.9; 95% CI 0.83, 0.98, p < 0.015) identified those less at risk for intubation.
Conclusion: NIV was found to be both safe and effective in the management of acute hypercapneic respiratory
failure. Sepsis and serum HCO3 at admission identified patients having poor outcomes (JPMA 60:13; 2010).
period, the first application of NIV was used for analysis. We
excluded patients with haemodynamic instability, impending
respiratory arrest, inability to protect airway, excessive airway
secretions, pneumothorax, acute upper gastrointestinal
bleeding, epistaxis, facial deformity/trauma and those with a
known hypersensitivity to the mask material.
We applied NIV using BiPAP Vision (Respironics,
Murrysville, Pa., USA) in the spontaneous mode with the
assistance of pulmonary fellows/ residents and trained nurses.
All NIV was initiated in either the Emergency department,
Special Care Units or the Intensive Care Unit. As soon as
possible, patients on NIV were transferred to a dedicated NIV
Special Care Unit. Therapy was initiated with an inspiratory
positive airway pressure (IPAP) of 10 cmH2O and an
expiratory positive airway pressure (EPAP) of 5 cmH2O. This
was optimized using continuous pulse oximetry readings
(aiming to maintain saturation between 92-95%), arterial
blood gas measurements (at 1 hour and periodically thereafter
as clinically indicated) and assessment of patient comfort.
Three oronasal masks were available to optimize patient
comfort: small, medium /small and medium, tightly secured
with head straps to minimize leaks. NIV was applied initially
for at least 6 hours, lengthening this period according to the
patients' requirements. 
The discontinuation of NIV was based on clinical
judgment and arterial blood gas values.
Patients exhibiting respiratory pauses with loss of
alertness or gasping, psychomotor agitation requiring
sedation, systolic blood pressure lower than 70 mmHg, pH
below 7.26 after 1 hour of NIV or respiratory arrest, were
endotracheally intubated. 
A pre-designed structured format was used to gather
data on demographic features, clinical features, arterial
blood gas measurements, duration of NIV and reasons for
NIV failure. 
The primary outcome variables were endotracheal
intubation rate (failure of NIV) and survival to hospital
discharge. A secondary study outcome was to identify
variables predictive of in-hospital mortality and
endotracheal intubation. 
The data was analyzed as frequencies for nominal
variables and as means ±standard deviation for continuous
variables. Univariate analyses was performed using the chi2
test or Fisher's exact test for nominal variables and the t test
for means. 
To identify factors predictive of mortality whilst using
noninvasive ventilation, a univariate analysis was done to
compare characteristics in patients surviving to hospital
discharge and those that died during hospitalization. Variables
with p values less than 0.10 were entered into a forward
stepwise logistic regression analysis using an entry level of
0.05 and a removal level of 0.10. The adjusted odds ratio (OR)
was calculated with 95% confidence intervals (95% CI) for all
independent predictors of in-hospital mortality. A similar
process was used to determine variables predictive of failure
of NIV. A p value less than 0.05 was considered statistically
significant; all tests were two tailed. SPSS statistical software
package (version 14.0) was used for statistical analysis.
Results
One hundred and nineteen patients with hypercapneic
ARF were enrolled in the study. Mean age of patients was 63.4
± 11.9 years with 63 (52.9%) males. COPD was the primary
cause of hypercapneic respiratory failure in 109 (91.6%)
patients, with acute asthma exacerbations accounting for the
remainder. All patients were haemodynamically stable at
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Figure-1: Change in pH after application of noninvasive ventilation.
Figure-2: Change in PaCO2 after application of noninvasive ventilation.
presentation; the mean systolic BP was 129 ± 24.5 mmHg,
mean heart rate 102.5 ± 21 beats/minute. The mean respiratory
rate was 27.7 ± 8.4 breaths/minute. Mental status was reduced
(drowsy) in 67 (56.3%) patients. Code status was defined in
93% patients on admission; 59% were full code, whilst 34.5%
were not for any resuscitation (DNR). 
At initiation of NIV, mean pH was 7.28 ±0.08, mean
PaCO2 74.2 ± 20.3 mmHg, mean PaO2 84.4 ± 44.2 mmHg
and mean HCO3 35.2 ± 8 mg/dl. In the succeeding 24 and 48
hour evaluations, there were significant improvements in the
PaCO2 {68.1 ± 21.7 mmHg, p < 0.001 at 24 hrs and 65
mmHg ±17.22, p < 0.001 at 48 hours} and pH {7.32 ± 0.08
, p < 0.001 at 24 hrs and 7.37 ± 0.7, p < 0.001 at 48 hours}
(Figures-1, 2). 
No significant changes were observed in serum HCO3
or PaO2. Noninvasive ventilation was applied for an average
duration of 12.2 ± 5.5 hours on day 1 and then the duration
was gradually decreased over succeeding days.
The average length of hospitalization was 11.4 ± 11
days. NIV failure and need for endotracheal intubation was
observed in 15 (12.6%) patients. Ninetyone (76.5%) patients
survived to hospital discharge and 28 (23.5%) patients died.
Pneumonia, worsening respiratory failure and pulmonary
oedema were the most common causes of death. Out of 28
non-survivors, code status of 20 patients was already decided
as not for any resuscitation (DNR) considering severity of
preexisting disease and other comorbidities. Six (21.42%)
patients died after intubation on mechanical ventilation and
remaining 22 (79.35%) were on NIV. Complications were
nosocomial pneumonia in 20 (16.8%), acute coronary
syndrome in 6 (5%) and pneumothorax in 3 (2.5%).
On univariate analysis, factors associated with a higher
risk of NIV failure or intubation were; pH less than 7.20 (p
0.011), serum HCO3 less than 35 meq/L (p 0.015) and serum
creatinine greater than 1.5 mg/dl (p 0.001) at admission. On
multivariate analysis the only independent predictor of a
reduced likelihood of endotracheal intubation was a serum
HCO3 greater than 35 meq/L at admission (Adjusted Odds
ratio 0.9; 95% CI 0.83, 0.98, P < 0.015).
Univariate analysis of the overall series showed that
factors associated with a reduced risk of in-hospital mortality
included; a diagnosis of COPD, younger age, the absence of
sepsis at admission, higher serum HCO3 and pH at admission
and a higher pH after 48hrs of NIV (Table).
On multivariate analysis the only remaining
independent predictor of in-hospital mortality was Sepsis
at admission, (adjusted Odds ratio 26.4; 95% CI 2.29,
304.3, p < 0.009). 
Figure-3 shows the change in pH after application of
noninvasive ventilation between survivors and nonsurvivors.
Discussion
This study found that NIV was equally safe and
efficacious in Pakistan as reported in patients from more
developed health care systems. It was observed that patients
presenting with co-existing sepsis and hypercapneic ARF
were at a higher risk of dying in the hospital. Patients
presenting with serum HCO3 values less than 35Meq/L were
at a greater risk of failing NIV and requiring invasive
ventilation.
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Figure-3: Change in pH on arterial blood gases after application of noninvasive
ventilation between survivors compared to nonsurvivors.
Table: Factors associated with Survival on univariate analysis of patients placed on noninvasive ventilation.
Factor Patients who Patients who Odds Ratio P-value
Survived Died (95% CI)
( n=91) ( n=28)
Age (in years) 62.1 ± 12.5 67.8 ± 8.7 0.94 (0.90,0.99) 0.029
Serum Creatinine 1.1 ± 0.5 1.7 ± 08 0.3 (0.14,0.61) 0.001
pH at base line 7.31± 0.09 7.25 ± 0.09 2.2 (0.8,6.5) 0.005
HCO3 (at baseline) 36.1 ± 7.5 32.4 ± 9.3 1.06 (1.0,1.1) 0.032
pH at 48 hours 7.39 ± 0.07 7.33 ± 0.06 3.7 (1.0,13.5) 0.002
Sepsis at admission 1 (1%) 3 (10.7%) 0.38 (0.003,0.43) 0.009
COPD as the Cause of Respiratory failure 2 (20%) 8 (80%) 0.056 (0.01,0.28) < 0.001
Though NIV is well accepted and used across the west,
there are very few regional descriptions of NIV usage. In
2004, Hussain S.F et al9 reported on an overall successful
experience with noninvasive ventilation in 69 patients with
various causes of acute respiratory failure. Similarly, we
reported the benefits of using NIV in COPD patients as an
adjunct to post-extubation respiratory failure.10 In 2006, Singh
et al11 from India also reported their favourable experience in
50 patients with all -cause acute respiratory failure. Our's is the
largest study reported so far from this region and thus adds
strength to the recommendations of using NIV even in poor,
underdeveloped health care systems.
In the presented study, a diagnosis other than COPD
was a risk factor for mortality. Literature has shown that NIV
is most effective in patients with hypercapneic ARF due to
COPD.12 There is little evidence for the efficacy of NIV in
hypercapneic ARF due to conditions other than COPD.
Although a meta-analysis suggests that NIV is more effective
in COPD exacerbations than other conditions4most studies in
non-COPD conditions involve hypoxaemic ARF and do not
focus on hypercapneic ARF.13,14 In our study, majority of
patients other than COPD group were asthmatic, with
significantly high mortality rates because of failure of
intubation. These patients were already decided DNR at the
time of admission secondary to multifactorial reasons. It is
known that hypercapneic ARF in these patients without
intubation has a bad prognosis.
A low pH at presentation has shown an association
with increased mortality15,16 and the need for intubation17 in
patients admitted with COPD exacerbations. These studies
have suggested that no improvement is observed in respiratory
acidosis and respiratory rates during the first few hours of NIV
and there is a higher likelihood of NIV failure.6,18 A fall in
PaCO219,20 and improvement in pH2,19-21 have also proved to
be protective. Our results are consistent with previously
published studies. The findings identified a low pH at
admission and failure to improve it for 48 hours, to be highly
predictive of mortality in patients initially placed on NIV.
Age was found to be a risk factor for mortality in the
presented study. Benhamou et al22 also reported a higher
rate of treatment failure in elderly patients while Balami et
al23 opined that NIV can be used successfully in elderly
patients admitted with hypercapneic respiratory failure
secondary to acute exacerbation of COPD. Their findings of
improvement of acidosis, respiratory rate and hypercapnia
from the use of NIV are consistent with findings of other
randomized trials conducted in a younger population.1-3
Increase failure rate in elderly patients may be due to
associated co-morbidities. This has been supported by
Seneff et al24 and Morettiet et al.25 Singh et al11 reported
that in patients with acute respiratory failure, presence of
one or more organ dysfunction was associated with failure
of NIV. Elevated creatinine and concurrent sepsis in our
patients was also associated with increase failure rate and
mortality which was consistent with finding of these
studies. Concurrent sepsis as an independent predictor of
mortality in our study has not been identified previously.
The presented study had limitations. There is
accumulating evidence regarding improved outcomes with
NIV in diverse patient groups with acute renal failure. This
has broadened the indications and may have created a
selection bias during the study period. The 'NIV service'
was introduced at our institution in 2001, and a "learning
and experience effect" on the team caring for patients could
have had an impact on the outcomes. The retrospective
nature of the data acquisition is another limitation. Lastly,
the study population was recruited from a single tertiary-
care center and this could affect the generalizability of the
findings. Despite these reservations, this survey provides
valuable information and is useful in demonstrating the
value of NIV in a low income country.
In conclusion, to the best of our knowledge, this is the
first study from Pakistan that has attempted to identify
variables predictive of outcome in patients with acute
hypercapneic respiratory failure treated with NIV. It is
recommended that NIV should be added to the standard
medical therapy for Pakistani patients with acute
exacerbations of COPD. The initial pH and PaCO2 can be
used clinically to stratify patients according to their risk of
meeting criteria for intubation. Monitoring such patients
closely is necessary to evaluate treatment responsiveness and
to facilitate endotracheal intubation if NIV fails. 
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